 Collaborative Research, Inc. was the first successful venture of this kind.Sato is co-inventor with his son, Denry Sato, and John Mendelson, CEO of University of Texas MD Anderson Cancer Center, of the original technology used in chemotherapeutic agents based on inhibiting the epidermal growth factor receptor as Cetuximab (Erbitux).While director of the Lake Placid Center from 1983 to 1992, Sato established the Manzanar Project named after the camp where he and his family were interned in 1942.